Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2008 May 23:8:15.
doi: 10.1186/1471-230X-8-15.

Time esophageal pH < 4 overestimates the prevalence of pathologic esophageal reflux in subjects with gastroesophageal reflux disease treated with proton pump inhibitors

Affiliations

Time esophageal pH < 4 overestimates the prevalence of pathologic esophageal reflux in subjects with gastroesophageal reflux disease treated with proton pump inhibitors

Lauren B Gerson et al. BMC Gastroenterol. .

Abstract

Background: A Stanford University study reported that in asymptomatic GERD patients who were being treated with a proton pump inhibitor (PPI), 50% had pathologic esophageal acid exposure.

Aim: We considered the possibility that the high prevalence of pathologic esophageal reflux might simply have resulted from calculating acidity as time pH < 4.

Methods: We calculated integrated acidity and time pH < 4 from the 49 recordings of 24-hour gastric and esophageal pH from the Stanford study as well as from another study of 57 GERD subjects, 26 of whom were treated for 8 days with 20 mg omeprazole or 20 mg rabeprazole in a 2-way crossover fashion.

Results: The prevalence of pathologic 24-hour esophageal reflux in both studies was significantly higher when measured as time pH < 4 than when measured as integrated acidity. This difference was entirely attributable to a difference between the two measures during the nocturnal period. Nocturnal gastric acid breakthrough was not a useful predictor of pathologic nocturnal esophageal reflux.

Conclusion: In GERD subjects treated with a PPI, measuring time esophageal pH < 4 will significantly overestimate the prevalence of pathologic esophageal acid exposure over 24 hours and during the nocturnal period.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Prevalence of pathologic 24-hour esophageal acidity assessed with integrated acidity and time pH < 4 in the index study (n = 46). The left panel gives prevalence with the 95% confidence interval. The right panel gives values for time pH < 4 from records with normal integrated acidity.
Figure 2
Figure 2
Prevalence of pathologic postprandial esophageal acidity assessed with integrated acidity and time pH < 4 in the index study (n = 46). The left panel gives prevalence with the 95% confidence interval. The right panel gives values for time pH < 4 from records with normal integrated acidity.
Figure 3
Figure 3
Prevalence of pathologic nocturnal esophageal acidity assessed with integrated acidity and time pH < 4 in the index study (n = 46). The left panel gives prevalence with the 95% confidence interval. The right panel gives values for time pH < 4 from records with normal integrated acidity.
Figure 4
Figure 4
Prevalence of pathologic esophageal acidity assessed with integrated acidity and time pH < 4 in the 3rd study (n = 52 records). Data are from 24-hour esophageal recordings on the 8th day of treatment with 20 mg omeprazole or 20 mg rabeprazole. Vertical bars give the 95% confidence interval.

References

    1. Milkes D, Gerson LB, Triadafilopoulos G. Complete elimination of reflux symptoms does not guarantee normalization of intraesophageal and intragastric pH in patients with gastroesophageal reflux disease (GERD) Am J Gastroenterol. 2004;99:991–996. doi: 10.1111/j.1572-0241.2004.30124.x. - DOI - PubMed
    1. Achem SR. Acid inhibition in GERD – How much is enough? Am J Gastroenterol. 2004;99:997–999. doi: 10.1111/j.1572-0241.2004.40316.x. - DOI - PubMed
    1. Gardner JD, Perdomo C, Sloan S, Hahne WF, Barth JA, Rodriguez-Stanley S, Robinson M. Integrated acidity and rabeprazole pharmacology. Aliment Pharmacol Ther. 2002;16:455–464. doi: 10.1046/j.1365-2036.2002.01158.x. - DOI - PubMed
    1. Gardner JD, Sloan S, Miner PB, Jr, Robinson M. Meal-stimulated gastric acid secretion and integrated gastric acidity in gastro-oesophageal reflux disease. Aliment Pharmacol Ther. 2003;17:945–953. doi: 10.1046/j.1365-2036.2003.01533.x. - DOI - PubMed
    1. Gardner JD, Young W, Sloan S, Robinson M, Miner PB., Jr The effects of changing temperature correction factors on measures of acidity calculated from gastric and esophageal pH recordings. Aliment Pharmacol Ther. 2006;23:629–638. doi: 10.1111/j.1365-2036.2006.02787.x. - DOI - PubMed

Publication types

MeSH terms